Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Leukemia

  Free Subscription


17.11.2025

2 Am J Hematol
3 Blood
2 BMC Cancer
1 Cancer Lett
1 Int J Hematol
3 Leuk Lymphoma
1 Leuk Res
3 Leukemia


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. GUOLO F, Fianchi L, Martelli MP, Lussana F, et al
    Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.
    Am J Hematol. 2025;100:2293-2304.
    PubMed         Abstract available

  2. TINAJERO J, Nguyen K, Ngo D, Agrawal V, et al
    The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease Burden.
    Am J Hematol. 2025;100:2209-2219.
    PubMed         Abstract available


    Blood


  3. Melnick AF, Mullin C, Lin K, et al. Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress. Blood. 2023;142(25):2159-2174.
    Blood. 2025;146:2493.
    PubMed        

  4. AL-SAWAF O, Furstenau M, Giza A, Robrecht S, et al
    The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL.
    Blood. 2025;146:2406-2416.
    PubMed         Abstract available

  5. CHEN C, Cai J, Wu X, Hu Q, et al
    Risk factors and outcomes of asparaginase-associated pancreatitis in pediatric patients with ALL.
    Blood. 2025;146:2417-2427.
    PubMed         Abstract available


    BMC Cancer

  6. AGHAYAN AH, Arab A, Haddadi S, Mirazimi Y, et al
    Investigating the prognostic value of non-coding RNAs in chronic lymphocytic leukemia: insights from a systematic review and meta-analysis.
    BMC Cancer. 2025;25:1739.
    PubMed         Abstract available

  7. CAI Q, Ye B, Zheng W, Zhang S, et al
    Development of a screening model for APL using cell population data and deep learning-extracted WBC scattergram features.
    BMC Cancer. 2025;25:1725.
    PubMed         Abstract available


    Cancer Lett

  8. JIANG Y, Liu F, Yang Y, Huang J, et al
    Bone marrow-based highly sensitive proteomics profiling reveals valuable biomarkers for pediatric B-cell acute lymphoblastic leukemia.
    Cancer Lett. 2025 Nov 11:218130. doi: 10.1016/j.canlet.2025.218130.
    PubMed         Abstract available


    Int J Hematol

  9. KATAYAMA S, Moriya K, Imamura T, Tamefusa K, et al
    Outcome of chemotherapy dose reduction in overweight Japanese children with acute lymphoblastic leukemia.
    Int J Hematol. 2025 Nov 10. doi: 10.1007/s12185-025-04103.
    PubMed        


    Leuk Lymphoma

  10. GUO X, Wang X, Wang Y, Rong L, et al
    Long-term remission of CBFA2T3::GLIS2-positive pediatric acute myeloid leukemia with myeloid sarcoma following unrelated cord blood transplantation.
    Leuk Lymphoma. 2025 Nov 13:1-4. doi: 10.1080/10428194.2025.2584684.
    PubMed        

  11. CHEVILLON F, Dhedin N, Boissel N
    Allogeneic hematopoietic stem cell transplantation in adult with acute lymphoblastic leukemia: evolving indications and modalities in shifting landscape.
    Leuk Lymphoma. 2025 Nov 13:1-13. doi: 10.1080/10428194.2025.2584685.
    PubMed         Abstract available

  12. VALDOVINOS-ELIZALDE LE, Rios-Olais FA, Hernandez-Felix JH, Vasquez-Ortiz ZY, et al
    Prognostic value of HFA-ICOS risk assessment for cancer therapy-related cardiovascular toxicity in adults with acute lymphoblastic leukemia.
    Leuk Lymphoma. 2025 Nov 11:1-9. doi: 10.1080/10428194.2025.2583445.
    PubMed         Abstract available


    Leuk Res

  13. ITONAGA H, Miyazaki Y, Fujioka M, Kurosawa S, et al
    Differential impact of graft-versus-host disease on post-transplant outcomes of chronic myelomonocytic leukemia according to transplant procedures.
    Leuk Res. 2025;159:108134.
    PubMed         Abstract available


    Leukemia

  14. LOCATELLI F, Rizzari C, Gruhn B, Klingebiel T, et al
    Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study.
    Leukemia. 2025 Nov 13. doi: 10.1038/s41375-025-02800.
    PubMed        

  15. ZHENG H, Zhang L, Li L
    Correspondence to "Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis".
    Leukemia. 2025 Nov 12. doi: 10.1038/s41375-025-02812.
    PubMed        

  16. DHIR A, Ethell A, Watkins R, Lam C, et al
    The splicing factor PTBP1 interacts with RUNX1 and is required for leukemia cell survival.
    Leukemia. 2025 Nov 10. doi: 10.1038/s41375-025-02799.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.